Leading healthcare technology firm Medtronic is reportedly looking to acquire UK-based Smith & Nephew, a deal reports say could shift Medtronic’s finances overseas.
The US firm, which is the largest manufacturer of heart rhythm technologies, is evaluating a possible acquisition of the London company, which currently has a market value of nearly $16 billion. While unnamed sources first broke news of the possible merger, they noted that a deal has not been struck and preparations for a bid are only in their preliminary stage.
But a Medtronic offer for Smith & Nephew would rival one from rival US medial tech company Stryker, which confirmed last week that it was also considering placing a bid for the UK company./p>
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI